Since previous studies have shown that cGAS expression levels are comparable between SLE patients and healthy individuals, we performed quantitative analysis of IFN-β and STING to assess the activity of cGAS-STING signaling. The gene discussed is STING1; the disease is systemic lupus erythematosus.